Feature Channels:

Pharmaceuticals

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Science

Channels:

Cell Signaling, G-Proteins, Pharmacology, Biochemistry & Biophysics, Cancer

Inside the World of Cell Signaling: A G-Protein Breakthrough

Scientists have few good methods for manipulating and investigating G-protein signaling. Now, UNC scientists have developed small proteins to selectively block a certain type of G-protein signaling, creating a unique and powerful tool for studying cell processes that depend on this signaling.

Medicine

Channels:

Merkely, Durbin, DeFazio, crna, aana, VA proposed rule, Oregon, Democrat Illinois, Democrat Oregon

Lawmakers Support Increasing Access to Anesthesia Care for Veterans; Rally Behind Nurse Anesthetists

Legislators Merkley, DeFazio and Durbin stand behind CRNAs and against anesthesiologists in support of Veterans receiving more timely healthcare.

Medicine

Channels:

Antibiotics, Burn Injury, burn injury infections, multidrug-resistant, Ut Southwestern

UT Southwestern Study Identifies a Way to Prevent Burn Injury Infection – Without Antibiotics

wolf-orth-huebinger-body.jpg

A new way to fight multidrug-resistant bacteria by blinding them rather than killing them proved highly effective in a model of burn injuries, UT Southwestern Medical Center research shows.

Medicine

Science

Channels:

Cancer, Drug Design, Drug Development

Scripps Florida Scientists Discover New Natural Source of Potent Anti-Cancer Drugs

Shen_authors.JPG

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed an efficient process to rapidly discover new “enediyne natural products” from soil microbes that could be further developed into extremely potent anticancer drugs.

Medicine

Channels:

Latest Analysis From Clarity Science Opera Pain Study Confirms 45% Reduction of Opioid Usage by Using Transdermal Medication

/PRNewswire/ -- Clarity, a global international scientific research company, based in Austin, Texas, announces the latest results of its IRB-approved OPERA study. OPERA (Optimizing Patient Experience and Response to Topical Analgesics) evaluates patient perceptions of pain treatment with the use of FDA-approved topical/transdermal formulations alone or in combination with neuropathic supplements via a patient-reported survey.

Medicine

Channels:

Pancreatic Cancer, Asprin, Yale Cancer Center, Epidemeology, Biomarker

Regular Aspirin Use May Reduce Risk for Pancreatic Cancer

HarveyRisch.jpeg

Regular use of aspirin by people living in Shanghai, China, was associated with decreased risk for developing pancreatic cancer, according to data published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

Medicine

Channels:

Aspirin, Cancer Prevention, Colorectal Cancer, evidence-based practice , Neoplasia, Polyps, science of health care delivery

Colorectal Cancer Prevention: A Proven Benefit of Nonsteroidal Anti-Inflammatory Drugs

Mayo Clinic researchers and a team of collaborating scientists from across the country have determined the comparative effectiveness of nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin and several supplements in preventing the recurrence of advanced neoplasia (polyps that are the precursor of colorectal cancer) after polyp removal.

Medicine

Channels:

Pharmaceucticals

Garret FitzGerald, MD, FRS, Awarded an Honorary Fellowship by British Pharmacological Society

FitzGeraldApril2012windowcloseupSLP.jpg

Garret A. FitzGerald, MD, FRS, director of the Institute for Translational Medicine and Therapeutics in the Perelman School of Medicine at the University of Pennsylvania, has been awarded an honorary fellowship by the British Pharmacological Society.

Science

Channels:

Diabetes, Biochemistry, Molecular Biology, Pharma

Metformin Reverses Metabolic Memory in a Diabetes Model

A recent Paper of the Week published in the Journal of Biological Chemistry examines how cells recovering from damage induced by a high-fat diet can be treated with a drug for type 2 diabetes called metformin to reverse the effects of metabolic memory.

Medicine

Channels:

dmitri simberg, University Of Colorado Cancer Center, Nanoparticles, Nanotechnology, Immunology, Immune System, Complement System, nature nanotechnology

How to Keep Nanoparticle "Caterpillars" Safe From The "Crows" of the Immune System

Simberg.Complement.png

A University of Colorado Cancer Center paper published today in the journal Nature Nanotechnology details how the immune system recognizes nanoparticles, potentially paving the way to counteract or avoid this detection.

Medicine

Channels:

Emily Kendall, arbs, TB, Regimen, Treatment, MDR

Computer Model Predicts Potential Impact of Short-Course Therapy Against Multidrug-Resistant TB

Lungs_Tuberculosis_Infection_iStock-505047773SMALL.jpg

Johns Hopkins researchers have developed a computer simulation that helps predict under which circumstances a new short-course treatment regimen for drug-resistant tuberculosis could substantially reduce the global incidence and spread of the disease.

Medicine

Channels:

drug prices, Health Insurance, Pharmaceutical Prices, Lixian Zhong

Why Are Prescription Drugs So Expensive?

pills-pixabay.jpg

It’s no secret that the cost of prescription drugs—especially brand-name drugs—has been rising far faster than inflation over the last few years. This high cost is one reason that some people aren’t taking the medication their providers prescribe for them.

Medicine

Channels:

Drug Discovery And Development, Translational Science, Wistar, GSK

The Wistar Institute Announces GSK Visiting Professor to Promote Academic-Industry Research Collaboration, Accelerate Drug Discovery

Wistarimagefornewsreleases.jpg

Wistar welcomes Kenneth W. Hance, Ph.D., M.P.H., Director of Antibody Therapies, Immuno-Oncology & Combinations DPU at GlaxoSmithKline (GSK), as its first Visiting Professor from GSK at Wistar.

Medicine

Channels:

Endocrine Society, Endocrinologists, Endocrinology, Diabetes, Diabetes & Endocrinology, Insulin, drug prices, drug pricing, Access To Health Care, Eli Lilly and Company

Endocrine Society Supports Improved Insulin Access

The Endocrine Society today praised Eli Lilly and Company’s announcement that it will offer discounted prices on insulin products purchased through certain online platforms as a step toward addressing increasing insulin prices.

Medicine

Channels:

Newly Revealed Amino Acid Function Could Be Used to Boost Antioxidant Levels

129194_web.jpg

Protecting the body against oxidative stress

Medicine

Channels:

Trustees

Hank Nordhoff Elected Chairman of Sanford Burnham Prebys Medical Discovery Institute Board of Trustees

Henry-Hank-Nordhoff.jpeg

Hank Nordhoff, Chairman and CEO of Banyan Biomarkers and Chairman of Chugai Pharmaceutical USA, is the new Chairman of SBP's Board of Trustees.

Medicine

Channels:

Aspirin, Colon Cancer, Pancreatic Cancer, Blood, Platelets, Cancer

Aspirin Slows Growth of Colon, Pancreatic Tumor Cells

Researchers have found that aspirin may slow the spread of some types of colon and pancreatic cancer cells. The study looks at the interaction between aspirin and blood platelets in cancer cells.

Medicine

Channels:

Molecular Biology, Cancer, Hepatology, Liver Cancer, Pathology, Liver Diseases, Non-alcoholic fatty liver disease , non-alcoholic steatohepatitis

Unexpected Activity of Two Enzymes Helps Explain Why Liver Cancer Drugs Fail

mouse_livers_shp2_and_Pten.jpg

Researchers at University of California San Diego School of Medicine have discovered that lack of two types of enzymes can lead to liver disease and cancer in mice. In human liver tumors, they found that deficiencies in these two enzymes, Shp2 and Pten, are associated with poor prognosis. The study, published December 13 by Cell Reports, provides a new understanding of liver cancer development, new therapeutic approach and new mouse model for studying the disease.

Medicine

Channels:

HIV, Hepatitis C, Sovaldi, Harvoni, Biomedical Science, Pharmacetical

Bad Combination: Hepatitis C and HIV Medications Can Interact Adversely When Used Together

University of Rhode Island pharmacy professor has discovered potential complications when Hepatitis C and HIV drugs are used in combination with additional medications to combat co-infections.

Medicine

Channels:

National Academy of Inventors, Drug Discovery

Drug Discovery Scientist Mark Suto Named to National Academy of Inventors

SUTOsr-1645.jpg

Mark J. Suto, Ph.D., vice president of Drug Discovery at Southern Research, has been named a Fellow of the National Academy of Inventors (NAI) in recognition of his wide-ranging contributions to pharmaceutical research and drug discovery efforts.







Chat now!